These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 6208770

  • 21. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 22. Antiarrhythmic drug therapy of ventricular arrhythmias.
    Huang SK, Marcus FI.
    Curr Probl Cardiol; 1986 Apr 01; 11(4):177-240. PubMed ID: 3086035
    [No Abstract] [Full Text] [Related]

  • 23. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction.
    Tai CT, Chiang CE, Lee SH, Chen YJ, Yu WC, Feng AN, Ding YA, Chang MS, Chen SA.
    J Cardiovasc Electrophysiol; 1999 Sep 01; 10(9):1180-7. PubMed ID: 10517649
    [Abstract] [Full Text] [Related]

  • 24. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P.
    G Ital Cardiol; 1986 Apr 01; 16(4):328-32. PubMed ID: 2427383
    [Abstract] [Full Text] [Related]

  • 25. Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy.
    Heger JJ, Hubbard J, Zipes DP, Miles WM, Prystowsky EN.
    Am J Cardiol; 1984 Nov 14; 54(9):40D-44D. PubMed ID: 6496368
    [Abstract] [Full Text] [Related]

  • 26. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)].
    Beck OA, Hochrein H.
    Dtsch Med Wochenschr; 1978 Aug 11; 103(32):1261-5. PubMed ID: 78793
    [Abstract] [Full Text] [Related]

  • 27. Clinical applications of antiarrhythmic drugs.
    Lavenne F, de Jonghe D.
    Acta Cardiol Suppl; 1980 Aug 11; (25):27-42. PubMed ID: 6155012
    [No Abstract] [Full Text] [Related]

  • 28. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ, Kates RE, Lebsack CS, Echt DS, Mason JW, Winkle RA.
    Am J Cardiol; 1983 Dec 01; 52(10):1208-13. PubMed ID: 6359849
    [Abstract] [Full Text] [Related]

  • 29. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
    Chilson DA, Heger JJ, Zipes DP, Browne KF, Prystowsky EN.
    J Am Coll Cardiol; 1985 Jun 01; 5(6):1407-13. PubMed ID: 3889099
    [Abstract] [Full Text] [Related]

  • 30. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ.
    Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B.
    Clin Ter; 1983 Apr 15; 105(1):3-11. PubMed ID: 6189663
    [No Abstract] [Full Text] [Related]

  • 33. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ, Anderson JL.
    Am J Cardiol; 1996 Aug 15; 78(4):430-4. PubMed ID: 8752188
    [Abstract] [Full Text] [Related]

  • 34. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP.
    Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902
    [Abstract] [Full Text] [Related]

  • 35. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F, Bracchetti D, Palmieri M, Cantelli I, Bertaccini P, Ambrosioni E.
    Am Heart J; 1985 Apr 16; 109(4):833-40. PubMed ID: 3885700
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N, Papadopoulos N, Papanastasiou S, Kozirakis M, Maligkos G, Tsaritsaniotis E, Katsaris G.
    Pacing Clin Electrophysiol; 2005 Sep 16; 28(9):954-61. PubMed ID: 16176535
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA, Murphy ML, Baker BJ, deSoyza N, Franciosa JA.
    Am J Cardiol; 1985 Jun 01; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [Abstract] [Full Text] [Related]

  • 38. Management of serious cardiac arrhythmias with drugs.
    Echt DS, Mason JW.
    Cardiovasc Clin; 1984 Jun 01; 14(3):191-209. PubMed ID: 6426796
    [No Abstract] [Full Text] [Related]

  • 39. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF, Mercer CJ, Roche AH, Lowe JB.
    N Z Med J; 1981 Jan 28; 93(676):31-5. PubMed ID: 6940024
    [Abstract] [Full Text] [Related]

  • 40. Effect of SU 13197, a new antiarrhythmic agent, on atrial arrhythmias: preliminary study.
    Dreifus LS, Lim HF, Rabbino MD, Watanabe Y.
    Am J Cardiol; 1968 Apr 28; 21(4):544-8. PubMed ID: 5645997
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.